We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$11.9B
AUM Growth
+$1.4B
Cap. Flow
+$748M
Cap. Flow %
6.3%
Top 10 Hldgs %
12.11%
Holding
747
New
202
Increased
220
Reduced
153
Closed
161

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$134M
2
STM icon
STMicroelectronics
STM
+$103M
3
META icon
Meta Platforms (Facebook)
META
+$89.9M
4
MET icon
MetLife
MET
+$71.9M
5
GILD icon
Gilead Sciences
GILD
+$70.3M

Top Sells

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$161M
2
LLY icon
Eli Lilly
LLY
+$153M
3
MRSH
Marsh
MRSH
+$123M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$91.8M
5
EA icon
Electronic Arts
EA
+$79.5M

Sector Composition

Rank Sector Weight
1 Healthcare 43.43%
2 Technology 17.4%
3 Industrials 8.07%
4 Energy 6.4%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BABA icon
226
Alibaba
BABA
$308B
$15.1M 0.13%
142,277
-93,530
-40% -$7.65M
CSCO icon
227
Cisco
CSCO
$479B
$15.1M 0.13%
282,978
-293,611
-51% -$14.3M
GIS icon
228
General Mills
GIS
$19.2B
$15M 0.13%
+203,541
New +$14.1M
RARE icon
229
Ultragenyx Pharmaceutical
RARE
$2.46B
$14.9M 0.13%
267,555
+765
+0.3% +$39K
MTH icon
230
Meritage Homes
MTH
$4.88B
$14.7M 0.12%
+143,276
New +$13.5M
VRNA
231
DELISTED
Verona Pharma
VRNA
$14.6M 0.12%
507,945
+6,747
+1% +$166K
RNR icon
232
RenaissanceRe
RNR
$13.4B
$14.6M 0.12%
53,505
-203,209
-79% -$49M
GPCR icon
233
Structure Therapeutics
GPCR
$3.59B
$14.6M 0.12%
331,573
-5,828
-2% -$225K
SPRY icon
234
ARS Pharmaceuticals
SPRY
$532M
$14.3M 0.12%
986,007
+704,863
+251% +$8.38M
AA icon
235
Alcoa
AA
$12.6B
$14.2M 0.12%
+369,308
New +$12.6M
GWW icon
236
W.W. Grainger
GWW
$60.7B
$14.2M 0.12%
13,715
+4,168
+44% +$4.03M
CP icon
237
Canadian Pacific Kansas City
CP
$80.4B
$14.2M 0.12%
165,649
+10,492
+7% +$863K
X
238
PUT
DELISTED
US Steel
X
$14.1M 0.12%
400,000
-300,000
-43% -$11.4M
IFF icon
239
International Flavors & Fragrances
IFF
$22.5B
$14.1M 0.12%
134,444
-109,248
-45% -$10.9M
EWTX icon
240
Edgewise Therapeutics
EWTX
$4.84B
$14.1M 0.12%
527,839
+106,235
+25% +$2.11M
BNTX icon
241
BioNTech
BNTX
$23.3B
$14M 0.12%
117,785
+5,247
+5% +$482K
CHX
242
DELISTED
ChampionX
CHX
$13.9M 0.12%
460,000
– –
ACI icon
243
Albertsons Companies
ACI
$5.75B
$13.7M 0.12%
739,999
-260,000
-26% -$5.09M
IMNM icon
244
Immunome
IMNM
$2.89B
$13.5M 0.11%
924,392
+1,500
+0.2% +$21.3K
MBX
245
MBX Biosciences
MBX
$3.21B
$13.5M 0.11%
+519,675
New +$11.9M
VSH icon
246
Vishay Intertechnology
VSH
$5.09B
$13.5M 0.11%
712,618
-935,326
-57% -$19.5M
AFG icon
247
American Financial Group
AFG
$12.2B
$13.4M 0.11%
99,841
+10,995
+12% +$1.42M
LYFT icon
248
Lyft
LYFT
$6.26B
$13.4M 0.11%
+1,051,054
New +$12.6M
BILI icon
249
Bilibili
BILI
$7.78B
$13.4M 0.11%
571,899
+186,022
+48% +$2.89M
AMRX icon
250
Amneal Pharmaceuticals
AMRX
$5.89B
$13.3M 0.11%
1,604,531
+289,508
+22% +$2.26M
8 9
10
11 12

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Woodline Partners held 747 positions worth $11.9B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Woodline Partners deployed $748M of net new capital in Q3 2024, opening 202 new positions and adding to 220 existing holdings. Its largest new stake was ASML: 149,876 shares worth $125M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Eli Lilly, an estimated $153M trimmed.

  • Woodline Partners's largest Q3 2024 buy was ASML: 149,876 shares worth $125M.
  • Woodline Partners added most to STMicroelectronics in Q3 2024, an estimated $103M increase.
  • Woodline Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $153M.
  • Woodline Partners fully exited TE Connectivity in Q3 2024, selling an estimated $161M.
  • Woodline Partners's ten largest holdings make up 12% of its $11.9B portfolio in Q3 2024.
  • Woodline Partners opened 202 new positions and closed 161 in Q3 2024.
  • Woodline Partners's portfolio value rose 13% quarter-over-quarter to $11.9B.

Based on Woodline Partners's 13F filing for Q3 2024, filed 14 Nov 2024.